ZA986337B - Pyrazine derivatives their preparation and medicaments containing them - Google Patents

Pyrazine derivatives their preparation and medicaments containing them

Info

Publication number
ZA986337B
ZA986337B ZA986337A ZA986337A ZA986337B ZA 986337 B ZA986337 B ZA 986337B ZA 986337 A ZA986337 A ZA 986337A ZA 986337 A ZA986337 A ZA 986337A ZA 986337 B ZA986337 B ZA 986337B
Authority
ZA
South Africa
Prior art keywords
ch2oh
alk
choh
equal
preparation
Prior art date
Application number
ZA986337A
Other languages
English (en)
Inventor
Georges Bashiardes
Jean-Christophe Carry
Michel Evers
Bruno Filoche
Serge Mignani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of ZA986337B publication Critical patent/ZA986337B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965—Non-condensed pyrazines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C07D213/82—Amides; Imides in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
ZA986337A 1997-07-17 1998-07-16 Pyrazine derivatives their preparation and medicaments containing them ZA986337B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9709058A FR2766187B1 (fr) 1997-07-17 1997-07-17 Derives de pyrazine, leur preparation et les medicaments les contenant

Publications (1)

Publication Number Publication Date
ZA986337B true ZA986337B (en) 1999-01-27

Family

ID=9509300

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA986337A ZA986337B (en) 1997-07-17 1998-07-16 Pyrazine derivatives their preparation and medicaments containing them

Country Status (24)

Country Link
US (1) US6399613B1 (no)
EP (1) EP1001944B1 (no)
JP (1) JP4443036B2 (no)
KR (1) KR20010021901A (no)
CN (1) CN1264371A (no)
AT (1) ATE251144T1 (no)
AU (1) AU747127B2 (no)
BR (1) BR9810880A (no)
CA (1) CA2296727C (no)
DE (1) DE69818679T2 (no)
DK (1) DK1001944T3 (no)
ES (1) ES2205536T3 (no)
FR (1) FR2766187B1 (no)
HU (1) HUP0004602A3 (no)
IL (1) IL134040A0 (no)
MX (1) MXPA00000280A (no)
NO (1) NO20000198L (no)
NZ (1) NZ501906A (no)
PL (1) PL338148A1 (no)
PT (1) PT1001944E (no)
RU (1) RU2194703C2 (no)
SK (1) SK482000A3 (no)
WO (1) WO1999003844A1 (no)
ZA (1) ZA986337B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9905771D0 (en) * 1999-03-12 1999-05-05 Isis Innovation Compounds
US7598278B2 (en) 2002-04-11 2009-10-06 L'oreal Administration of pyridinedicarboxylic acid compounds for stimulating or inducing the growth of human keratinous fibers and/or arresting their loss
WO2007124025A2 (en) * 2006-04-20 2007-11-01 Teva Pharmaceutical Industries Ltd. Methods for preparing eszopiclone crystalline form a, substantially pure eszopiclone and optically enriched eszopiclone
US20080015197A1 (en) * 2006-06-26 2008-01-17 Alex Mainfeld Process for the preparatrion of zopiclone
WO2008094690A2 (en) * 2007-01-31 2008-08-07 Teva Pharmaceutical Industries Ltd. Methods for preparing eszopiclone
CN101891679B (zh) * 2009-05-19 2014-04-16 上海华明高技术（集团）有限公司 吡啶二甲酸与二氨基吡啶质子转移化合物的制备方法
FR3030248B1 (fr) 2014-12-22 2018-03-23 L'oreal Association derive d'acide pyridine-dicarboxylique/agent anti-oxydant particulier

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220650A (en) * 1978-10-18 1980-09-02 Pfizer Inc. Organic diamine therapeutic compositions and methods
DE3703959A1 (de) * 1987-02-10 1988-08-18 Hoechst Ag Pyridin-2,4- und 2,5-dicarbonsaeureamide, verfahren zu ihrer herstellung, verwendung derselben sowie arzneimittel auf basis dieser verbindungen
JPH01117863A (ja) * 1987-10-30 1989-05-10 Toyobo Co Ltd 新規なアミド化合物
DE4020570A1 (de) * 1990-06-28 1992-01-02 Hoechst Ag 2,4- und 2,5-substituierte pyridin-n-oxide, verfahren zu deren herstellung sowie deren verwendung

Also Published As

Publication number Publication date
DE69818679D1 (de) 2003-11-06
DE69818679T2 (de) 2004-07-29
JP2001510188A (ja) 2001-07-31
HUP0004602A3 (en) 2001-12-28
SK482000A3 (en) 2000-06-12
FR2766187A1 (fr) 1999-01-22
JP4443036B2 (ja) 2010-03-31
BR9810880A (pt) 2002-05-21
CN1264371A (zh) 2000-08-23
EP1001944A1 (fr) 2000-05-24
ES2205536T3 (es) 2004-05-01
IL134040A0 (en) 2001-04-30
AU8810298A (en) 1999-02-10
NZ501906A (en) 2002-04-26
NO20000198D0 (no) 2000-01-14
WO1999003844A1 (fr) 1999-01-28
PL338148A1 (en) 2000-09-25
EP1001944B1 (fr) 2003-10-01
NO20000198L (no) 2000-01-14
DK1001944T3 (da) 2004-02-09
ATE251144T1 (de) 2003-10-15
US6399613B1 (en) 2002-06-04
CA2296727C (fr) 2009-06-09
AU747127B2 (en) 2002-05-09
KR20010021901A (ko) 2001-03-15
HUP0004602A2 (hu) 2001-11-28
FR2766187B1 (fr) 2000-06-02
MXPA00000280A (es) 2002-04-17
RU2194703C2 (ru) 2002-12-20
CA2296727A1 (fr) 1999-01-28
PT1001944E (pt) 2004-02-27

Similar Documents

Publication Publication Date Title
SI0641767T1 (en) Cytotoxic stilbene derivatives and pharmaceutical composition containing them
FI965020A (fi) Uusia yhdisteitä, menetelmiä niiden valmistamiseksi ja kasvaintenvastaisia aineita
FR2672598B1 (no)
ES8405274A1 (es) Procedimiento para preparar composiciones farmaceuticas inyectadas que contienen derivados de 2-metil-3-carboxamida-4-hidroxitiazina 1,1-dioxido.
IL70905A0 (en) Carbacycline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA986337B (en) Pyrazine derivatives their preparation and medicaments containing them
ES8506979A1 (es) Procedimiento para preparar nuevas sales de alquil (cadena larga) amonio de n-fosfonometilglicina
HUP9900088A2 (hu) Pirimidinszármazékok, ezeket tartalmazó gyógyászati készítmények és eljárás előállításukra
DE69029781D1 (de) Anthracyclinglycosid-Derivate und Verfahren zu ihrer Herstellung
HK1032916A1 (en) N,n'-bis(sulfonyl)hydrazines useful as antineoplastic agents
AU539348B2 (en) 5,6,8,9-tetrahydro-7h-dibenz(d,f)azonine derivatives
BG101942A (en) Analogues of arginine having inhibiting activity on no-synthetase
ES8203917A1 (es) Un procedimiento para la preparacion de un derivado de nu- cleosido de adenina
TW328083B (en) New derivatives of β-methoxy acrylic acid, their preparation process and their use as pesticides
DK1001943T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
IL106080A (en) Pharmaceutical compositions containing amidinoalkane-1, 1-bisphosphonic acids and some such novel compounds
IL86795A (en) 8-substituted ergoline-6-oxide derivatives,their preparation and pharmaceutical compositions containing them
ATE44281T1 (de) Benzoselenino(4,3,2-cd>indazolverbindungen, diese enthaltende zubereitungen und verfahren zu ihrer herstellung.
ES2061864T3 (es) Sustancia antitumoral, procedimiento para su preparacion, y agente anticanceroso que la contiene.